Imperial Capital, LLC
Imperial Capital Continues Its Growth of the Emerging Markets Sales & Trading Group with the Hiring of John Gibbens in London
LOS ANGELES, April 24, 2017 (GLOBE NEWSWIRE) -- Imperial Capital Group, LLC ("Imperial Capital") announced today the continued expansion of its dedicated Emerging Markets Group with the hiring of John Gibbens, Managing Director, at Imperial Capital (International) LLP ("Imperial UK") in London. Mr. Gibbens will report to Andrew Gold, Head of Emerging Markets Sales & Trading, and Brian Robertson, Head of Imperial UK.
"We are excited to have John join the Emerging Markets effort at Imperial Capital," said Andrew Gold, Managing Director and Head of Emerging Markets Sales and Trading group at Imperial Capital, LLC. "We continue to build an incredibly strong team with years of experience in the Emerging Markets business and John is one of several expected London-based hires as we further develop our CEEMEA focus, and continue to add to the product offering we provide to our clients."
Mr. Gibbens joins Imperial UK with over 20 years of leadership experience in relationship management and Emerging Markets, having most recently worked in the Emerging Markets sales group at Investec Bank plc. Prior to Investec, Mr. Gibbens was a Managing Director and ran the Emerging Markets Credit Sales and Trading Desk at Jefferies International Limited in London. He has also headed / occupied senior positions on Emerging Markets trading desks at ABN AMRO/RBS, Commerzbank and Daiwa Securities Europe. He spent 7 years with Deutsche Bank as a Director of Global Markets and Fixed Income secondary market trader with a focus on Eastern Europe. Mr. Gibbens graduated with First Class BSc (Hons) Psychology degree from the University of Hertfordshire in the United Kingdom.
About Imperial Capital, LLC
Imperial Capital is a full-service investment bank offering a uniquely integrated platform of comprehensive services to institutional investors and middle market companies. We offer sophisticated sales and trading services to institutional investors and a wide range of investment banking advisory, capital markets and restructuring services to middle market corporate clients. Paired with our proprietary research and sales & trading desk analysis, we provide investment analysis across an issuer's capital structure, including bank loans, debt securities, the hybrid/bank capital marketplace (through our ELP Framework), post-reorganization equities, special situations claims and listed and unlisted equities. Our comprehensive and integrated service platform, expertise across the global capital structure, and deep industry sector knowledge enable us to provide clients with research driven ideas, superior advisory services, and trade execution. We are quick to identify opportunities under any market conditions and we have a proven track record of offering creative, proprietary solutions to our clients. Imperial Capital has three principal businesses: Investment Banking, Institutional Sales & Trading and Institutional Research. More information about Imperial Capital can be found at www.imperialcapital.com .
About Imperial Capital (International), LLP
Imperial Capital International, founded in 2011, is an affiliate of Imperial Capital, LLC with an office in central London. Complementing Imperial Capital's existing fixed income sales and trading franchise, Imperial Capital (International), LLP expanded the Imperial Capital franchise into the EEA. The company focuses on selling the entire credit spectrum and capital structure to its European institutional clients.
For more information regarding Imperial Capital, LLC, founded in 1997, please contact: Mark Martis Chief Operating Officer (310) 246-3674 firstname.lastname@example.org For more information regarding Imperial Capital (International), LLP, please contact: Brian Robertson Managing Director 44 (0) 207 650 5401 email@example.com
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Nasdaq OMX
XBiotech, Inc18.10.2017 16:54 | pressemeddelelse
XBiotech Announces First Patient in Study Evaluating MABp1 in Combination with Onivyde® and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer
Nasdaq18.10.2017 15:44 | pressemeddelelse
Nasdaq and SGX Establish Collaborative Listings Agreement
Colliers International Group Inc.18.10.2017 14:32 | pressemeddelelse
Colliers International Expands in Washington, D.C.
InSphero AG18.10.2017 14:01 | pressemeddelelse
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC
Kofax, Inc.18.10.2017 08:02 | pressemeddelelse
Kofax Wins "Most Innovative Solution for Banking Customer Authentication" Award for Third Consecutive Year
IASLC18.10.2017 06:26 | pressemeddelelse
World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum